Clot Management Devices Global Market Report 2024

The clot management devices market size has grown strongly in recent years. It will grow from $1.63 billion in 2023 to $1.72 billion in 2024 at a compound annual growth rate (CAGR) of 6%. The expansion observed during the historical period can be attributed to several factors, including the rising aging population, regulatory approvals and clinical trials for clot management devices, growing awareness and screening programs for cardiovascular diseases, and the increasing prevalence of cardiovascular conditions.

The clot management devices market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be attributed to several factors, including rising healthcare expenditure, improvements in healthcare infrastructure, favorable regulatory and reimbursement policies, increased adoption of telemedicine and remote monitoring solutions, and the growing acceptance of personalized medicine approaches. Key trends expected in the forecast period encompass technological advancements, the development of innovative next-generation thrombectomy tools, personalized treatment strategies, collaborations and partnerships within the healthcare industry, and the integration of artificial intelligence and machine learning for enhanced patient care.

The projected increase in demand for hospitals is set to drive the growth of the clot management device market in the foreseeable future. Hospitals, specialized healthcare facilities catering to medical treatment, care, and services for individuals with diverse illnesses, injuries, or medical conditions, are on the rise due to several factors such as aging populations, urbanization, improved healthcare access, population growth, and medical tourism. Clot management devices play a pivotal role in the healthcare sector, serving as essential tools for treating conditions such as deep vein thrombosis, pulmonary embolism, and ischemic strokes. These devices offer patients effective and minimally invasive solutions, thereby enhancing overall treatment outcomes and ensuring patient safety. For example, data from the American Health Care Association reveals an increase in the number of hospitals in the US from 5,129 in 2022 to 6,120 in May 2024. Consequently, the growing demand for hospitals is fueling the expansion of the clot management device market.

Key players in the clot management device market are focusing on developing innovative technologies, such as computer-assisted vacuum thrombectomy (CAVT) systems, to meet the evolving needs of customers. Computer-assisted vacuum thrombectomy (CAVT) systems are medical devices utilized in treating blood clots, particularly in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). For instance, in April 2024, Penumbra Inc., a US-based medical company, introduced the Lightning Flash 2.0, the latest clot aspiration and vacuum thrombectomy technology. This cutting-edge device offers rapid blood clot removal, representing a significant advancement in clot management devices. The Lightning Flash 2 integrates advanced artificial intelligence and sophisticated engineering to enhance patient outcomes in both acute and chronic care settings. Equipped with advanced imaging and suction capabilities, it enables precise and efficient clot removal to address various medical scenarios.

In September 2021, Boston Scientific, a US-based medical technology company, acquired Devoro Medical to further strengthen its market position and broaden its range of treatment options for patients with thrombotic disorders. Devoro Medical, a US-based company, specializes in producing medical devices for treating peripheral veins and arteries with diverse clot morphologies and vessel diameters.

Major companies operating in the clot management devices market are Cardinal Health Inc., Bayer AG, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, DePuy Synthes Inc., Terumo Corporation, Edwards Lifesciences Corporation, Acandis GmbH & Co. KG, Cook Medical, Merit Medical Systems Inc., Applied Medical Resources Corporation, Penumbra Inc., MicroVention Inc., Inari Medical Inc., AngioDynamics Inc., Argon Medical Devices Inc., LeMaitre Vascular Inc., iVascular S.L.U., Straub Medical AG, Rapid Medical.

North America was the largest region in the clot management devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clot management devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the clot management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A clot management device is a medical instrument crafted to prevent, manage, or eliminate blood clots within the vascular system. These devices are instrumental in treating blood clots, particularly concerning vascular conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).

The primary product categories within the clot management devices market include neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF). Neurovascular embolectomy devices are specialized tools employed to extract clots from blood vessels in the brain. Percutaneous thrombectomy devices encompass various types such as aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices, catering to end-users such as diagnostic centers and hospitals.

The clot management devices market research report is one of a series of new reports that provides clot management devices market statistics, including clot management devices industry global market size, regional shares, competitors with a clot management devices market share, detailed clot management devices market segments, market trends, and opportunities, and any further data you may need to thrive in the clot management devices industry. This clot management devices research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clot management devices market consists of sales of catheter-directed thrombolysis systems, thrombectomy devices, and inferior vena cava (IVC) filters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.